United States · Series B startup

Who invested in Alantos Pharmaceuticals

2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$20Mraised across 2 rounds since 2003, from 2 sources

Latest round
Series B, $20MMar 2005
Investors
6
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

200320042005
?Round$20MSeries B
First round
Round
Feb 2003
Biggest round
$20M
Series B · Mar 2005
Between rounds
2.1 years
from the last two

The rounds

  1. Mar 2005
  2. Feb 2003
    RoundAmount undisclosed1 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

The exit

ExitBuyerPriceWhen
AcquiredAmgenundisclosedJun 2007

From historical deal records. Wrong? Tell us.

Everyone who backed them

VentechVC firm1round
SV Life SciencesVC firm1round
Oxford Bioscience PartnersGrowth equity1round
ABN AMRO FundCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Alantos Pharmaceuticals

Who invested in Alantos Pharmaceuticals?

Alantos Pharmaceuticals's investors include Earlybird Venture Capital, Ventech, SV Life Sciences, Oxford Bioscience Partners and ABN AMRO Fund, and 1 more on record.

How much has Alantos Pharmaceuticals raised?

Alantos Pharmaceuticals has raised $20M across 2 rounds since 2003. One round did not disclose an amount, so the total is a floor.

When did Alantos Pharmaceuticals last raise?

Alantos Pharmaceuticals's most recent round was a Series B of $20M in Mar 2005.

What was Alantos Pharmaceuticals's biggest round?

Its most recent round, $20M in Mar 2005, is also its largest on record.

Who backed Alantos Pharmaceuticals first?

Alantos Pharmaceuticals's first round on record, in Feb 2003, was backed by Earlybird Venture Capital.

What stage is Alantos Pharmaceuticals at?

Alantos Pharmaceuticals's latest named round is a Series B, in Mar 2005.

Where is Alantos Pharmaceuticals based?

Alantos Pharmaceuticals is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.